Results 131 to 140 of about 20,539 (229)

Survival among patients with systemic sclerosis‐associated pulmonary arterial hypertension in the Australian scleroderma cohort study

Internal Medicine Journal, EarlyView.
Abstract Background and Aims Systemic sclerosis (scleroderma; SSc) patients can develop pulmonary arterial hypertension (PAH), which is a leading cause of death. We sought to evaluate severity, therapeutic strategy and survival of SSc‐PAH in the Australian Scleroderma Cohort Study (ASCS).
Zoe Brown, Dylan Hansen, Kathleen Morrisroe, Nava Ferdowsi, Laura Ross, Wendy Stevens, Maryam Tabesh, Joanne Sahhar, Gene‐Siew Ngian, Diane Apostolopoulos, Kimti Kumar, Jennifer G. Walker, Susanna Proudman, Mandana Nikpour   +13 more
wiley   +1 more source

Comparison of rituximab vs. cyclophosphamide in rheumatoid arthritis-associated interstitial lung disease and its correlation with spirometry

The Journal of Association of Chest Physicians
Introduction: Rheumatoid arthritis-associated interstitial lung disease (RA-ILD) is a significant health concern affecting a substantial population in India. This study outlines the limitations of current treatment options.
Mohammed Abdullah Saleem, Atiya Parveen, Fazeel Zubair Ahmed   +2 more
doaj  

Assessing the quality of end‐of‐life care in systemic sclerosis

Internal Medicine Journal, EarlyView.
Abstract Background Systemic sclerosis (SSc) is a rare autoimmune disease with the highest mortality among rheumatic diseases, yet little is known about the quality of end‐of‐life care in SSc. Aims To evaluate end‐of‐life care in SSc against the Australian National Consensus Statement's Essential Elements for high‐quality end‐of‐life care and compare ...
Julie McDonald, Lisa Kiven, Sophia To, Navera Ahmed, Laura Ross   +4 more
wiley   +1 more source

The worldwide burden of skin diseases: Lessons from the Global Burden of Disease data

Journal of the European Academy of Dermatology and Venereology, EarlyView.
Skin diseases are a major public health concern worldwide, causing significant personal, economic and social burdens. The Global Burden of Disease (GBD) initiative provides valuable insights but underestimates the burden of skin diseases, emphasizing the urgent need for improved data collection and global collaboration among stakeholders.
Luigi Naldi, Simone Cazzaniga, Carsten Flohr, Marco May Lee, Claire Fuller, Roderick Hay, Esther E. Freeman, Rashmi Sarkar, Ricardo Romiti, Antonio Torrelo, Qianjin Lu, Ncoza Dlova, Visnja Zaborski Breton, Jennifer Austin, Matthias Augustin, Henry Lim, Luca Borradori   +16 more
wiley   +1 more source

Letermovir in Refractory and Resistant CMV After Lung Transplantation: Therapeutic Potential and Emergence of Resistance

Transplant Infectious Disease, EarlyView.
Letermovir use for active R/R CMV infection was associated with treatment‐emergent resistance in approximately one‐third of patients, particularly in those with high baseline viral loads and delayed virological response. These findings support careful patient selection, close virological monitoring, and early resistance testing.
Tobias Veit, Stefan Trost, Teresa Kauke, Nina Engels, Gabriela Leuschner, Michael Gerckens, Carlo Mümmler, Sebastian Michel, Michael Zoller, Valeria Hackemann, Jürgen Behr, Nikolaus Kneidinger   +11 more
wiley   +1 more source

What Matters to Homeowners When Managing Flood Risk: Values‐Informed Mental Models for Integrating Community Priorities Into Risk Analysis

Community Science, Volume 5, Issue 4, December 2026.
Abstract Climate‐risk analyses designed to inform adaptation decisions should reflect the values, knowledge, and lived experiences of affected communities. However, most existing frameworks remain centered on economic metrics and give limited consideration to non‐economic drivers of adaptation behavior.
C. Cooper, C. Helgeson, C. L. C. Troy, L. D. Iulo, N. Tuana, K. Keller   +5 more
wiley   +1 more source

Successful Whole Lung Lavage in a Patient With Lipoid Pneumonia

Open Respiratory Archives
Marc Paredes, Mari Paz Fuset-Cabanes, Lara Pijuan, Roger Llatjós, Marta Diez-Ferrer, Belén Del Río, Sandra Orozco, Vanesa Vicens-Zygmunt   +7 more
doaj   +1 more source

Aumolertinib Versus Osimertinib as First‐Line Treatment for EGFR‐Mutant Non‐Small Cell Lung Cancer: A Retrospective Real‐World Multicenter Study

International Journal of Cancer, Volume 159, Issue 10, Page 2575-2584, 15 November 2026.
As third‐generation EGFR‐tyrosine kinase inhibitors, both aumolertinib and osimertinib demonstrate clinical efficacy for non‐small cell lung adenocarcinoma, especially in patients with brain metastases. Currently, head‐to‐head studies comparing these two agents in real‐world settings are scarce.
Jinxia Wang, Ping Qi, Jinhua Li, Na Wang, Caihong Fu, Lixin Liu, Shuping Li, Xiao Li, Xiaoming Hou, Hui Qiao   +9 more
wiley   +1 more source

Characteristics and Outcomes of Male Participants in a Multicenter Longitudinal Australian Study Cohort

Arthritis Care &Research, Volume 78, Issue 11, Page 1701-1710, November 2026.
Objective The aim of this study was to determine the differences in demographic, serologic, and clinical characteristics between male and female patients with systemic sclerosis (SSc) in an Australian cohort. Methods This was a retrospective observational study using data from the Australian Scleroderma Cohort Study.
Emily Lin, Dylan Hansen, Laura Ross, Gene‐Siew Ngian, Susanna Proudman, Gabor Major, Maryam Tabesh, Mandana Nikpour, Jennifer Walker, Lauren Host, Nava Ferdowsi, Alannah Quinlivan, Wendy Stevens, Joanne Sahhar, Diane Apostolopoulos   +14 more
wiley   +1 more source

Performance Status as a Prognostic Factor in Japanese Patients With Myeloperoxidase–Antineutrophil Cytoplasmic Antibody–Positive Microscopic Polyangiitis

ACR Open Rheumatology, Volume 8, Issue 11, November 2026.
Objective This observational study investigated the impact of performance status (PS) on prognosis following remission induction therapy in patients with myeloperoxidase (MPO)–antineutrophil cytoplasmic antibody–positive microscopic polyangiitis (MPA).
Tokio Katakura, Ken‐ei Sada, Masayoshi Harigai, Yuki Nakamura, Shouichi Fujimoto, Yukio Yuzawa, Kunihiro Yamagata, Masaki Kobayashi, Tatsuya Atsumi, Takahiko Sugihara, Naoto Tamura, Yoshihiro Arimura, Hirofumi Makino, Izaya Nakaya   +13 more
wiley   +1 more source